Scientists at Yale Cancer Center found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.
Recently, a friend lent me a copy of a decades-old report, and by old, I mean a classic.
